Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc (Press release)
Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg (link)
Paragraph IV litigation:
1) Merck & Co., Inc Vs Hetero Drugs & Invagen Pharmaceuticals (No patent/product traced); Filed on November 19, 2010
2) Ortho-McNeil Vs Mylan & Famycare (Product may be “Ortho Tri-Cyclen”) filed on November 12, 2010; Famycare and Mylan have tie up for USA contraceptive market; As per thier agreement two companies will jointly file ANDA for approval of at least 22 new oral contraceptives with the US FDA (Link).
For these two litigation will be updated soon with patent details